Reziz 25 mg/500 mg Tablet is a combination of two medicines: Pyrimethamine and Sulphadoxine which treat malaria. Pyrimethamine is an antiparasitic medicine which works by increasing the levels of haeme in the blood, a substance toxic to the malarial parasite. This kills the parasite and stops the infection from spreading. Sulphadoxine is an antibiotic which stops the bacteria from producing folic acid, a nutrient required for bacterial multiplication.
Interaction with alcohol is unknown. Please consult your doctor.
WEIGH RISKS VS BENEFITS
Reziz 25 mg/500 mg Tablet may be unsafe to use during pregnancy. Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
Reziz 25 mg/500 mg Tablet is probably unsafe to use during lactation.
Limited human data suggest that the drug could represent a significant risk to the baby.
It is not known whether Reziz 25 mg/500 mg Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Reziz 25 mg/500 mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Reziz 25 mg/500 mg Tablet may be needed. Please consult your doctor.
Reziz 25 mg/500 mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Reziz 25 mg/500 mg Tablet may be needed. Please consult your doctor.
“The following are the results of on-going survey on 1mg.com for Reziz 25 mg/500 mg Tablet. These results only indicate the perceptions of the website users. Please base your medical decisions only on the advice of a doctor or a registered medical professional.”
Information last updated by Dr. Varun Gupta, MD Pharmacology on 1st Dec 2017.